RETINA-AI Health CEO, Dr Stephen Odaibo, visits with Duke University's Topmost Leadership to Discuss AI

RETINA-AI Health’s Founder, CEO, and Chairman of the Board, Dr. Stephen Odaibo, a triple Duke Alumnus, was recently invited to visit Duke. During the visit he was received by the University’s topmost leadership: the University President Vince Price, the Dean of the Medical School Dr. Mary Klotman, and the Vice Provost of Research & University Vice President, Dr. Larry Carin. The purpose of the invitation was to explore ways in which RETINA-AI Health, Inc and Duke University can collaborate and build a meaningful partnership that advances each others’ AI work. Duke recognizes RETINA-AI’s unique position as a leader at the intersection of Artificial Intelligence and Healthcare. Dr. Odaibo is a practicing Retina Specialist as well as a Mathematician, Computer Scientist, and hands-on Full-Stack AI Engineer who leads RETINA-AI’s excellent and growing team of Data Engineers. Similarly, RETINA-AI recognizes Duke’s strength as a top research University with a top Medical School, from where Dr. Odaibo obtained his medical degree; he also completed his graduate Computer Science training and his Internal Medicine intern year at Duke.

Duke University has strategically set its sights on interdisciplinary Artificial Intelligence and intends to invest heavily in AI/ML in the coming years. Dr. Odaibo maintains strong ties with Duke University where he topped the class in Neurology and in Pediatrics and received the 2005 Barrie Hurwitz Award for Excellence in Neurology. And where he and four other alumni seeded the Dr. Brenda Armstrong Endowment Fund.

“It was wonderful to be so well-received on my recent visit to my alma mater, Duke University. I stayed at the Washington Duke Inn and Golf Course, was given presidential parking on the Quad, and was given a personal tour of the medical school by Vice President of Development, Sarah Nicholson. My meetings with the leadership left me feeling assured that our school is in capable hands. What was most exciting for me was to hear Duke’s clear vision of an AI-powered future in healthcare, and how RETINA-AI Health and Duke will be a key part of writing that future,” Odaibo said.

President of Duke University, Dr. Vincent Price (Left) with RETINA-AI Health, Inc Founder, CEO, and Chairman of the Board, Dr. Stephen Odaibo (Right)

President of Duke University, Dr. Vincent Price (Left) with RETINA-AI Health, Inc Founder, CEO, and Chairman of the Board, Dr. Stephen Odaibo (Right)

Dean of Duke Medical School, Dr. Mary Klotman (Left) with RETINA-AI Health, Inc Founder, CEO, and Chairman of the Board, Dr. Stephen Odaibo (Right)

Dean of Duke Medical School, Dr. Mary Klotman (Left) with RETINA-AI Health, Inc Founder, CEO, and Chairman of the Board, Dr. Stephen Odaibo (Right)

Duke Vice Provost of Research and University Vice President, Dr. Lawrence Carin (Left) with RETINA-AI Health, Inc Founder, CEO, and Chairman of the Board, Dr. Stephen Odaibo (Right)

Duke Vice Provost of Research and University Vice President, Dr. Lawrence Carin (Left) with RETINA-AI Health, Inc Founder, CEO, and Chairman of the Board, Dr. Stephen Odaibo (Right)